Yes
Yes
Yes
Yes
Yes, interstitial radiation therapy can use radioactive isotopes of phosphorus, such as phosphorus-32, as a treatment for certain cancers. These radioactive sources are implanted directly into or near the tumor to deliver localized radiation therapy.
Yes, intracavitary radiation therapy can use iridium-192 sources. Iridium-192 is a common radioactive isotope used in brachytherapy for treating various cancers, including gynecological and prostate cancers. The radioactive source is placed inside or near the tumor to deliver targeted radiation treatment.
Patients receiving interstitial radiation do become temporarily radioactive
The radiation emited is gamma ray
Yes
The half value layer for iridium-192 is approximately 0.035 cm of lead. This means that the thickness of lead needed to reduce the radiation intensity by half is 0.035 cm when using iridium-192 as the radiation source.
Iridium has no uses at home.
Interstitial radiation therapy places the sources of radiation directly into the tumor and surrounding tissue.
The advantage is that it concentrates the radiation near the cancer and lessens the chance of damage to normal cells